EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PI3Kγ in Tumour Inflammation: Bridging Immune Response and Cancer Progression—A Mini‐Review

Anghesom Ghebremedhin, Judith A Varner iD

Immunology · 2025

DOI: 10.1111/imm.13959 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology, 2025. Verfasst von Anghesom Ghebremedhin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Moores Cancer Center, University of California, San Diego, California, USA. Hauptthemen laut MEDLINE: Neoplasms, Class Ib Phosphatidylinositol 3-Kinase, Inflammation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDCR NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphatidylinositol 3‐kinase gamma (PI3Kγ), a class I PI3K family member, plays a critical role in modulating inflammation and immune responses within the tumour microenvironment. Emerging evidence suggests that PI3Kγ promotes myeloid cell trafficking and transcription, leading to tumour progression and metastasis. This review explores the multifaceted roles of PI3Kγ in tumour‐associated inflammation, highlighting its involvement in immune cell polarisation, cytokine production, and the dynamic interaction between tumour cells and the surrounding stromal environment. We also discuss the potential therapeutic implications of targeting PI3Kγ to modulate inflammation and inhibit tumour growth. Given its pivotal role in immune response and tumour progression, PI3Kγ represents a promising target for future cancer therapies to reduce inflammation‐driven tumorigenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsClass Ib Phosphatidylinositol 3-KinaseInflammationHumansTumor MicroenvironmentAnimalsDisease ProgressionSignal TransductionCytokines

Stichwörter der Autor:innen

PI3KinasePI3Kγimmune suppressionintegrin activationmacrophagesmyeloid cellmyeloid‐derived suppressor cellspolarisationtumour microenvironment

Substanzen

Class Ib Phosphatidylinositol 3-KinasePIK3CG protein, humanCytokines

Autor:innen und Institutionen

  • Moores Cancer Center, University of California, San Diego, California, USA.
  • Department of Pathology, University of California, San Diego, California, USA.

ORCID-Profile: Judith A Varner

Förderung

  • NIH HHS
  • NIDCR NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Ghebremedhin, A., & Varner, J. A. (2025). PI3Kγ in Tumour Inflammation: Bridging Immune Response and Cancer Progression—A Mini‐Review. Immunology. https://doi.org/10.1111/imm.13959

Vancouver

Ghebremedhin A, Varner JA. PI3Kγ in Tumour Inflammation: Bridging Immune Response and Cancer Progression—A Mini‐Review. Immunology. 2025. doi:10.1111/imm.13959

BibTeX
@article{Ghebremedhin2025,
  author = {Ghebremedhin, Anghesom and Varner, Judith A},
  title = {PI3Kγ in Tumour Inflammation: Bridging Immune Response and Cancer Progression—A Mini‐Review},
  journal = {Immunology},
  year = {2025},
  doi = {10.1111/imm.13959}
}
Kostenlos starten →